Frailty Rehabilitation
Frailty is an important clinical state that contributes to falls, hospitalization, institutionalization and death. When an individual simultaneously has many health problems, a frailty "tipping point" may be triggered by even a minor stressful event such as adding a new drug or urinary tract infection. Our research sug
| Condition(s) | Frailty |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Frailty is an important clinical state that contributes to falls, hospitalization, institutionalization and death. When an individual simultaneously has many health problems, a frailty "tipping point" may be triggered by even a minor stressful event such as adding a new drug or urinary tract infection. Our research suggests that approximately 23% of Canadians over age 65 are frail, and by age 85 this estimate increases to over 40%. As we learn more about frailty and its consequences, there is an urgent need to develop community-based interventions that will prevent or delay frailty in older adults. Our proposed study will examine if frailty rehabilitation program is an effective community-based intervention to promote healthy aging. The primary objective of our study is to determine if 4-m |
| Who can participate | Inclusion Criteria: * Community-dwelling ≥65 years of age * Able to independently ambulate 25m with or without walking aid * At high risk for mobility disability/functional limitations * Received medical clearance * Can arrange transportation to the YMCA up to 2x/week * Proof of being fully vaccinated against COVID-19 and proof of identification Exclusion Criteria: * Unable to speak or understand English * Currently attending a group exercise program * Currently in a drug optimization study/program * Currently taking protein supplements daily * Significant cognitive impairment where they may have difficulty following two-step commands in group exercise * Receiving palliative/end of life care * Unstable angina or heart failure * Unable to attend for more than 20% of trial duration |
| Ages | 65 Years |
| Sex | All |
| Lead sponsor | McMaster University |
| Locations | Hamilton, Ontario, Canada |
| Start date | 2022-09-02 |
| NCT ID | NCT03824106 |
| Official listing | https://clinicaltrials.gov/study/NCT03824106 |